-
-
-
-
-
-
-
Galecto (GLTO) PT Raised to $36 at Guggenheim
-
-
-
-
-
-
-
Galecto (GLTO) Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines
-
-
408,233 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

